Reduced endogenous endothelin-1–mediated vascular tone in chronic renal failure
- 1 February 1999
- journal article
- clinical trial
- Published by Elsevier in Kidney International
- Vol. 55 (2) , 613-620
- https://doi.org/10.1046/j.1523-1755.1999.00291.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in HumansCirculation, 1996
- The endothelin system and its potential as a therapeutic target in cardiovascular diseasePharmacology & Therapeutics, 1996
- Endothelin ET A and ET B Receptors Cause Vasoconstriction of Human Resistance and Capacitance Vessels In VivoCirculation, 1995
- Contribution of endogenous generation of endothelin-1 to basal vascular toneThe Lancet, 1994
- ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1Published by Elsevier ,1994
- Endothelin-1 and endothelin-3 play different roles in acute and chronic alterations of blood pressure in patients with chronic hemodialysisBiochemical and Biophysical Research Communications, 1991
- Endothelin in Renal FailureNephrology Dialysis Transplantation, 1990
- PLASMA IMMUNOREACTIVE ENDOTHELIN IN URAEMIAThe Lancet, 1989
- PLASMA ENDOTHELIN LEVELS IN PATIENTS WITH URAEMIAThe Lancet, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988